CureVac
Viktoria Heberle is an experienced professional in the pharmaceutical and quality management sectors, currently serving as Group Manager Quality at CureVac since September 2022. Prior to this role, Viktoria held the position of Quality Manager Deviation at CureVac Real Estate GmbH from May 2020 to September 2022. Viktoria also has experience as an Apothekerin at Apotheke Sauter and completed internships at Luftschiff Apotheke and Roche, focusing on supplier quality management and other pharmacy-related responsibilities. Viktoria earned a 2. Staatsexamen in Pharmazie from the University of Tübingen, following an allgemeine Hochschulreife from Hegau Gymnasium Singen.
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.